Records containing: Transthyretin Amyloidosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-13Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
-
CLINICAL_TRIALS study record update · 2026-03-31The Eplontersen Pregnancy and Lactation Outcomes Study (EPPRO): A Descriptive Safety Study of Pregnant and Lactating Individuals and Their Offspring Exposed to Eplontersen
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of Acoramidis for Transthyretin Amyloidosis Prevention in the Young (ACT-EARLY Trial)
-
CLINICAL_TRIALS study record update · 2026-03-24A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients With Transthyretin (ATTR) Amyloidosis
-
CLINICAL_TRIALS study record update · 2026-03-12Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-25ATTRACT-52: Advancing TTR Testing and Risk-Based Amyloidosis Cardiac Screening in Primary Care - The Ordu Pilot Study
-
CLINICAL_TRIALS study record update · 2026-01-16Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy
-
CLINICAL_TRIALS study record update · 2026-01-05MyocardON-TTR - Myocardial Effects in Patients With Hereditary Transthyretin-mediated Amyloidosis With Polyneuropathy Treated With Patisiran or Vutrisiran
-
CLINICAL_TRIALS study record update · 2025-09-18Evaluation of a Claims-based Algorithm for the Identification of ATTR Amyloidosis in Medical Records
-
CLINICAL_TRIALS study record update · 2025-08-15Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis Among Patients Undergoing Carpal Tunnel Release Surgery - A Prospective Study
-
CLINICAL_TRIALS study record update · 2025-08-15Phenotyping and Characterization of Danish Wild-type Transthyretin Amyloidosis Cardiomyopathy Patients: A Cross-sectional Study
-
CLINICAL_TRIALS study record update · 2025-07-18A Follow-Up Study to Monitor Therapeutic Response in Transthyretin Cardiac Amyloidosis Using Amyloid Reactive Peptide 124I-evuzamitide (AT01) PET/CT
-
CLINICAL_TRIALS study record update · 2025-06-29Genetic Screening of an At-risk Population for Hereditary TransthyRetin-related AMyloidosis and Longitudinal Monitoring of TTR Positive Subjects- A Multicenter Epidemiological Longitudinal Protocol
-
CLINICAL_TRIALS study record update · 2025-04-10Retrospective Identification of Scintigraphic Cardiac Amyloidosis Using Deep Learning-based Model
-
CLINICAL_TRIALS study record update · 2024-12-09Prevalence and Prediction of Transthyretin Amyloidosis in Ambulatory Patients With Heart Failure With Preserved Ejection Fraction
-
CLINICAL_TRIALS study record update · 2024-12-03WI241665 2018 GLOBAL ASPIRE TTR Amyloidosis _ Transthyretin Amyloidosis National Registry - a Prospective Non-interventional, Longitudinal, Observational Multicentre Study
-
CLINICAL_TRIALS study record update · 2024-11-22Transthyretin Amyloidosis Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin Gene Mutations or Wild-Type Transthyretin Amyloidosis.
-
CLINICAL_TRIALS study record update · 2024-08-07Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Community Study
-
CLINICAL_TRIALS study record update · 2024-06-27A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects With Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM Trial)
-
CLINICAL_TRIALS study record update · 2024-06-11Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis
-
CLINICAL_TRIALS study record update · 2024-04-19Assessment of the Association of New Biomarkers (GDF15, ST2, Galectin-3, TIMP-1, MMP-9, NfL) and Plasma Prothrombotic Potential in the Course of Cardiac Transthyretin Amyloidosis
-
CLINICAL_TRIALS study record update · 2024-02-20Prevalence of Transthyretin Cardiac Amyloidosis in Patients With Idiopathic Carpal Tunnel Syndrome Referred for Release Surgery
-
CLINICAL_TRIALS study record update · 2023-10-19Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome in a Portuguese Population (CarPoS Study)
-
CLINICAL_TRIALS study record update · 2023-04-19The Comparisons of Regional Scintigraphic DPD Uptake Between Patients With Hereditary and Wild Type Cardiac Transthyretin Amyloidosis
-
CLINICAL_TRIALS study record update · 2023-02-10Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy - An International, Multicenter, Epidemiological Protocol